ofloxacin has been researched along with clindamycin phosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Chen, Q; Du, D; Du, Q; Duan, F; Fan, C; Guo, X; He, S; He, Y; Huang, B; Huang, W; Ji, C; Li, X; Liang, Y; Liu, X; Liu, Y; Ma, L; Wang, Y; Wei, Z; Wu, X; Xin, G; Xing, Z; Zeng, D; Zhang, R; Zhao, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for ofloxacin and clindamycin phosphate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for ofloxacin and clindamycin phosphate
| Article | Year |
|---|---|
Haloemodin as novel antibacterial agent inhibiting DNA gyrase and bacterial topoisomerase I.
Topics: Animals; Anti-Bacterial Agents; Emodin; Enterococcus faecium; Keratitis; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Rabbits; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2014 |